TaiGen to launch IPO and finance clinical drug trials

TaiGen to launch IPO and finance clinical drug trials

Taipei Times 20 Aug 2013 Drug maker TaiGen Biotechnology Co (太景生技) is set to debut its shares on the Emerging Stock Market by the end of this month and plans to use the IPO proceeds to finance clinical trials of its drugs, the company said yesterday. The Cayman...